Yiran Hu
- Hepatology top 2%
- Hepatitis C virus research 14
- Epidemiology top 10%
- Hepatitis B Virus Studies 5
- Infectious Diseases top 10%
- HIV/AIDS drug development and treatment 11
-
- Air Quality and Health Impacts 3
-
- Chronic Obstructive Pulmonary Disease (COPD) Research 5
-
- Systemic Lupus Erythematosus Research 3
-
- Metabolomics and Mass Spectrometry Studies 2
-
- Alzheimer's disease research and treatments 2
- Co-authors
- Linjing LiuChengshui ChenLino RodriguesQiang WangJiahao ZengH. W. ReesinkMassimo ColomboBeat Müllhaupt
- Partner nations
- United StatesChinaFrance
In The Last Decade
Yiran Hu
27 papers receiving 768 citations
Peers
Comparison fields: 5 of 104
- Hepatology 405
- Epidemiology 362
- Infectious Diseases 160
- Biological Psychiatry 17
- Health, Toxicology and Mutagenesis 90
Countries citing papers authored by Yiran Hu
This map shows the geographic impact of Yiran Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yiran Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yiran Hu more than expected).
Fields of papers citing papers by Yiran Hu
This network shows the impact of papers produced by Yiran Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yiran Hu. The network helps show where Yiran Hu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yiran Hu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2023 | 5 | |
| 4 | 2022 | 33 | |
| 5 | 2022 | 2 | |
| 6 | 2020 | 12 | |
| 7 | 2020 | 127 | |
| 8 | 2020 | 26 | |
| 9 | 2019 | 8 | |
| 10 | 2019 | 0 | |
| 11 | OUTCOMES OF PATIENTS INTERRUPTING GLECAPREVIR/PIBRENTASVIR TREATMENT: A CASE SERIES FROM CLINICAL TRIALS | 2019 | 2 |
| 12 | 2019 | 20 | |
| 13 | 2018 | 29 | |
| 14 | 2017 | 16 | |
| 15 | 2017 | 11 | |
| 16 | 2014 | 37 | |
| 17 | 2014 | 273 | |
| 18 | 2014 | 12 | |
| 19 | 2009 | 88 | |
| 20 | [Diagnostic value of tau in cerebrospinal fluid in alzheimer disease]. | 2001 | 5 |
About Yiran Hu
Yiran Hu is a scholar working on Hepatology, Infectious Diseases and Epidemiology, having authored 30 papers that have together received 789 indexed citations. Recurring topics across this work include Hepatitis C virus research (14 papers), HIV/AIDS drug development and treatment (11 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (5 papers), Hepatitis B Virus Studies (5 papers), Air Quality and Health Impacts (3 papers), Systemic Lupus Erythematosus Research (3 papers), Metabolomics and Mass Spectrometry Studies (2 papers) and Alzheimer's disease research and treatments (2 papers). The work is most often cited by research in Hepatology (405 citations), Epidemiology (362 citations) and Infectious Diseases (160 citations). Yiran Hu has collaborated with scholars based in United States, China and France. Frequent co-authors include Linjing Liu, Chengshui Chen, Lino Rodrigues, Qiang Wang, Jiahao Zeng, H. W. Reesink, Massimo Colombo, Beat Müllhaupt, Thomas Podsadecki and A Maieron. Their work appears in journals such as Open Forum Infectious Diseases, Gastroenterology, Biomarkers, Aging and Journal of the International AIDS Society.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.